COVID-19 Kills 1,700 People Globally A Week

WHO has urged people at risk to keep up with their vaccinations with boosters. IMAGE: A healthcare worker administers a dose of iNCOVACC, an intranasal vaccine as a booster dose for a senior......

Bharat Biotech finally names ICMR as co-owner in Covaxin patent filings

After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology......

'Poorly designed': ICMR on BHU Covaxin safety study

The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the Covaxin in adults and adolescents for......

Should Govt Continue Covid Vax Drive?

India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......

Budget 2025: Grassroot Level Implementation Is Necessary

Budget 2025 represents a crucial step towards empowering our youth, nurturing a sustainable startup ecosystem, and establishing India as a global leader in agriculture, medical tourism, and......

Modi urges global tech CEOs to be part of India growth story

Prime Minister Narendra Modi urged CEOs of US majors to take advantage of India's growth story as the country is making all efforts to become the third largest economy of the world in his third......

'Expect formulations biz to outpace API biz'

'API prices are dragging down margins and impacting our competitive ability.' Photograph: Kind courtesy Biocon Biocon delves into the evolving dynamics of the biosimilar market, with a focus on......

India's IPO market set to break May jinx in Lok Sabha election year

‘Sell in May, go away’ is a popular market adage. But ‘Don’t sell any new shares in May’ is the best kept secret of Dalal Street that’s set to break.......

Djokovic-owned biotech firm developing COVID treatment

IMAGE: The biotech firm, in which Novak Djokovic has an 80 per cent stake, has around 11 researchers working in Denmark, Australia and Slovenia, working on a treatment and not a vaccine according......